Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2020.0296


Accurate therapy in the adjuvant and neo-adjuvant setting.

Evangelos Mpaltagiannis, MD.


Prognosis of colorectal patients with unresectable tumors or progress after standardized multimodal treatment is dismal.
The new concept of multi-targeted therapy against intrapatient genetic heterogeneity applying targeted NGS (tNGS) represents now the most rational approach to potential survival. This mini-review evaluates the clinical utility of extensive gene panel in tumoral and liquid samples.
Despite the promising data of basket trials there is need to shift from current expert’s panel decision-making treatment to randomized clinical trials to establish drug commitment for agents approved for other CRC patients having genetic detectable alterations.

(Citation: Gastric & Breast Cancer 2020; 15(1): 43-51)

You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 16 January 2020